Abstract
The interest in regulatory T cells (Tregs) has been revived following the discovery of developing multiorgan autoimmune diseases as a result of depleting CD4+CD25+ T cells from mice. The importance of Tregs is being recognized in various clinical fields such as tumor and microbial immunities, transplantation and allergy. Prevalence of allergic diseases such as asthma, atopic dermatitis and rhinitis is significantly increasing worldwide. A better understanding of the mechanisms of T-cell regulation in allergic diseases may help in developing more effective therapeutic strategies. The well-known role of Tregs in preventing autoinumme diseases indicates that these important cells might be involved in prevention of allergy, and allergic diseases are associated with a low frequency and/or an impaired function of Tregs. Recent data show that natural CD4+CD25+ Tregs and interleukin (IL)-10-producing Tregs are normally able to suppress Th2 responses to allergens, while such suppression is diminished in allergic conditions. In this review, I summarize the role of Tregs in allergic diseases and discuss the possibility of manipulating these cells for treating allergic diseases.
| Original language | English |
|---|---|
| Pages (from-to) | 211-217 |
| Number of pages | 7 |
| Journal | Inflammation and Allergy - Drug Targets |
| Volume | 5 |
| Issue number | 4 |
| DOIs | |
| Publication status | Published - Dec 2006 |
| Externally published | Yes |
Fingerprint
Keywords
- Allergic diseases
- Asthma
- Regulatory T cells
- Therapeutic strategy
ASJC Scopus subject areas
- Immunology and Allergy
- Immunology
- Pharmacology
Cite this
Role of regulatory T cells in allergy : Implications for therapeutic strategy. / Elkord, Eyad.
In: Inflammation and Allergy - Drug Targets, Vol. 5, No. 4, 12.2006, p. 211-217.Research output: Contribution to journal › Review article
}
TY - JOUR
T1 - Role of regulatory T cells in allergy
T2 - Implications for therapeutic strategy
AU - Elkord, Eyad
PY - 2006/12
Y1 - 2006/12
N2 - The interest in regulatory T cells (Tregs) has been revived following the discovery of developing multiorgan autoimmune diseases as a result of depleting CD4+CD25+ T cells from mice. The importance of Tregs is being recognized in various clinical fields such as tumor and microbial immunities, transplantation and allergy. Prevalence of allergic diseases such as asthma, atopic dermatitis and rhinitis is significantly increasing worldwide. A better understanding of the mechanisms of T-cell regulation in allergic diseases may help in developing more effective therapeutic strategies. The well-known role of Tregs in preventing autoinumme diseases indicates that these important cells might be involved in prevention of allergy, and allergic diseases are associated with a low frequency and/or an impaired function of Tregs. Recent data show that natural CD4+CD25+ Tregs and interleukin (IL)-10-producing Tregs are normally able to suppress Th2 responses to allergens, while such suppression is diminished in allergic conditions. In this review, I summarize the role of Tregs in allergic diseases and discuss the possibility of manipulating these cells for treating allergic diseases.
AB - The interest in regulatory T cells (Tregs) has been revived following the discovery of developing multiorgan autoimmune diseases as a result of depleting CD4+CD25+ T cells from mice. The importance of Tregs is being recognized in various clinical fields such as tumor and microbial immunities, transplantation and allergy. Prevalence of allergic diseases such as asthma, atopic dermatitis and rhinitis is significantly increasing worldwide. A better understanding of the mechanisms of T-cell regulation in allergic diseases may help in developing more effective therapeutic strategies. The well-known role of Tregs in preventing autoinumme diseases indicates that these important cells might be involved in prevention of allergy, and allergic diseases are associated with a low frequency and/or an impaired function of Tregs. Recent data show that natural CD4+CD25+ Tregs and interleukin (IL)-10-producing Tregs are normally able to suppress Th2 responses to allergens, while such suppression is diminished in allergic conditions. In this review, I summarize the role of Tregs in allergic diseases and discuss the possibility of manipulating these cells for treating allergic diseases.
KW - Allergic diseases
KW - Asthma
KW - Regulatory T cells
KW - Therapeutic strategy
UR - http://www.scopus.com/inward/record.url?scp=33845626903&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33845626903&partnerID=8YFLogxK
U2 - 10.2174/187152806779010945
DO - 10.2174/187152806779010945
M3 - Review article
C2 - 17168791
AN - SCOPUS:33845626903
VL - 5
SP - 211
EP - 217
JO - Current Drug Targets: Inflammation and Allergy
JF - Current Drug Targets: Inflammation and Allergy
SN - 1871-5281
IS - 4
ER -